HIV-hepatitis C coinfection: Difference between revisions

From IDWiki
m (Aidan moved page HIV-Hepatitis C coinfection to HIV-hepatitis C coinfection without leaving a redirect)
mNo edit summary
Line 1: Line 1:
−
== Principles ==
 +
==Management==
   
−
* Confirm both diagnoses, including ensuring HCV RNA is still positive 6 months after first measured
 +
*Confirm both diagnoses, including ensuring HCV RNA is still positive 6 months after first measured
−
* Treat the HIV first, using any first-line regimen
 +
*Treat the HIV first, using any first-line regimen
−
* Treat the HIV for at least 2 weeks before starting HCV treatment
 +
*Treat the HIV for at least 2 weeks before starting HCV treatment
   
  +
===Choice of Antivirals===
−
== Regimens ==
  
   
−
* Consult [https://www.hep-druginteractions.org/checker HEP Drug Interactions checker]
 +
*Consult [https://www.hep-druginteractions.org/checker HEP Drug Interactions checker]
−
* Be careful with Harvoni, which can increase levels of tenofovir, especially when GFR <60 mL/min
 +
*Be careful with Harvoni, which can increase levels of tenofovir, especially when GFR <60 mL/min
   
 
{| class="wikitable"
  
{| class="wikitable"
−
! !! !! LDV/SOF !! SOF/VEL !! ELB/GRZ !! GLE/PIB !! SOF/VEL/VOX
 +
! !! !!LDV/SOF!!SOF/VEL!!ELB/GRZ!!GLE/PIB!!SOF/VEL/VOX
 
|-
  
|-
−
| rowspan = 3 | PI
 +
| rowspan="3" |PI
−
| [[ATV/r]]
 +
|[[ATV/r]]
−
| style="background:yellow" | A
 +
| style="background:yellow" |A
−
| style="background:yellow" | A
 +
| style="background:yellow" |A
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:red" |
+
| style="background:red" |
 
|-
  
|-
−
| [[DRV/r]]
 +
|[[DRV/r]]
−
| style="background:yellow" | A
 +
| style="background:yellow" |A
−
| style="background:yellow" | A
 +
| style="background:yellow" |A
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:yellow" |
+
| style="background:yellow" |
 
|-
  
|-
−
| [[LPR/r]]
 +
|[[LPR/r]]
−
| style="background:yellow" | A,ND
 +
| style="background:yellow" |A,ND
−
| style="background:yellow" | A
 +
| style="background:yellow" |A
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:red" | ND
 +
| style="background:red" |ND
 
|-
  
|-
−
| rowspan=4 | NNRTI
 +
| rowspan="4" |NNRTI
−
| [[DOR]]
 +
|[[DOR]]
 
| style="background:green" |
  
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
 
| style="background:green" |
  
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
 
|-
  
|-
−
| [[EFZ]]
 +
|[[EFZ]]
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:red" | ND
 +
| style="background:red" |ND
−
| style="background:red" | ND
 +
| style="background:red" |ND
 
|-
  
|-
−
| [[RPV]]
 +
|[[RPV]]
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
 
|-
  
|-
−
| [[ETR]]
 +
|[[ETR]]
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:red" | ND
 +
| style="background:red" |ND
−
| style="background:red" | ND
 +
| style="background:red" |ND
−
| style="background:red" | ND
 +
| style="background:red" |ND
−
| style="background:red" | ND
 +
| style="background:red" |ND
 
|-
  
|-
−
| rowspan=4 | INSTI
 +
| rowspan="4" |INSTI
−
| [[BIC]]
 +
|[[BIC]]
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" |
+
| style="background:green" |
 
|-
  
|-
−
| [[EVG/c]]
 +
|[[EVG/c]]
−
| style="background:yellow" | C
 +
| style="background:yellow" |C
−
| style="background:yellow" | C
 +
| style="background:yellow" |C
−
| style="background:red" |
+
| style="background:red" |
−
| style="background:yellow" |
+
| style="background:yellow" |
−
| style="background:yellow" | C
 +
| style="background:yellow" |C
 
|-
  
|-
−
| [[DTG]]
 +
|[[DTG]]
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
 
|-
  
|-
−
| [[RTG]]
 +
|[[RTG]]
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
 
|-
  
|-
−
| EI
 +
|EI
−
| [[MVC]]
 +
|[[MVC]]
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
 
|-
  
|-
−
| rowspan=5 | NRTI
 +
| rowspan="5" |NRTI
−
| [[ABC]]
 +
|[[ABC]]
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
 
|-
  
|-
−
| [[FTC]]
 +
|[[FTC]]
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
 
|-
  
|-
−
| [[3TC]]
 +
|[[3TC]]
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" | ND
 +
| style="background:green" |ND
 
|-
  
|-
−
| [[TDF]]
 +
|[[TDF]]
−
| style="background:yellow" | B,C
 +
| style="background:yellow" |B,C
−
| style="background:yellow" | B,C
 +
| style="background:yellow" |B,C
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:yellow" | C,D
 +
| style="background:yellow" |C,D
 
|-
  
|-
−
| [[TAF]]
 +
|[[TAF]]
−
| style="background:green" | D
 +
| style="background:green" |D
−
| style="background:green" | D
 +
| style="background:green" |D
−
| style="background:green" | ND
 +
| style="background:green" |ND
−
| style="background:green" |
+
| style="background:green" |
−
| style="background:green" | D
 +
| style="background:green" |D
 
|}
  
|}
   
−
* '''Green''' = safe; '''yellow''' = dose change or close monitoring; '''red''' = avoid
 +
*'''Green''' = safe; '''yellow''' = dose change or close monitoring; '''red''' = avoid
−
* '''ND''' = no data; '''A''' = caution with TDF only; '''B''' = increase in tenofovir possible; '''C''' = avoid TDF with eGFR < 60 mL/min; '''D''' = studied in fixed-dose combinations only
 +
*'''ND''' = no data; '''A''' = caution with TDF only; '''B''' = increase in tenofovir possible; '''C''' = avoid TDF with eGFR < 60 mL/min; '''D''' = studied in fixed-dose combinations only
   
−
== Further Reading ==
 +
==Further Reading==
   
−
* [https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/26/hcv-hiv &quot;Considerations for Antiretroviral Use in Patients with Coinfections&quot;], in ''Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV''. AIDSinfo.
 +
*[https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/26/hcv-hiv &quot;Considerations for Antiretroviral Use in Patients with Coinfections&quot;], in ''Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV''. AIDSinfo.
−
* [https://www.hcvguidelines.org/unique-populations/hiv-hcv &quot;Patients With HIV/HCV Coinfection&quot;], in ''HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C''. IDSA &amp; AASLD.
 +
*[https://www.hcvguidelines.org/unique-populations/hiv-hcv &quot;Patients With HIV/HCV Coinfection&quot;], in ''HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C''. IDSA &amp; AASLD.
   
 
[[Category:HIV]]
  
[[Category:HIV]]

Revision as of 08:47, 13 August 2020

Management

  • Confirm both diagnoses, including ensuring HCV RNA is still positive 6 months after first measured
  • Treat the HIV first, using any first-line regimen
  • Treat the HIV for at least 2 weeks before starting HCV treatment

Choice of Antivirals

LDV/SOF SOF/VEL ELB/GRZ GLE/PIB SOF/VEL/VOX
PI ATV/r A A
DRV/r A A
LPR/r A,ND A ND
NNRTI DOR ND ND ND
EFZ ND ND
RPV
ETR ND ND ND ND ND
INSTI BIC ND ND ND
EVG/c C C C
DTG ND
RTG ND
EI MVC ND ND ND ND ND
NRTI ABC ND ND ND
FTC
3TC ND ND ND
TDF B,C B,C C,D
TAF D D ND D
  • Green = safe; yellow = dose change or close monitoring; red = avoid
  • ND = no data; A = caution with TDF only; B = increase in tenofovir possible; C = avoid TDF with eGFR < 60 mL/min; D = studied in fixed-dose combinations only

Further Reading

Retrieved from "https://idwiki.org/index.php?title=HIV-hepatitis_C_coinfection&oldid=5927"
Powered by MediaWiki
Powered by Semantic MediaWiki